findmyKOL

Paula Marchetta, MD

Basic profile

Rheumatology

ORCIDNone on fileNPI↗
✓ Full record
RegionNew York, NY · NortheastSpecialtyRheumatologyFocusRheumatology/Immunology
Last active 2021findmyKOL type: RegionalLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Paula Marchetta is a Rheumatology/Immunology physician. OpenAlex indexes 13 publications with 1,007 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
13publications

Distinct works indexed by OpenAlex.

1,007citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

232 E 30th St
New York, NY 100168202

Telephone

212-696-5415

Provider last certified this registry record 14 Apr 2021.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    30.3%
    Folate Analog Metabolic Inhibitor13.1%
    Methotrexate100%
    Part D<11 patients
    TNF inhibitor7.7%
    Enbrel Sureclick61%Enbrel39%
    Part D<11 patients

    + 2 more classes in this area

  • Nervous system

    17.2%
    Gabapentinoids7.1%
    Gabapentin54%Pregabalin46%
    Part D<11 patients
    Nonsteroidal Anti-inflammatory Drug6.8%
    Meloxicam100%
    Part D<11 patients

    + 1 more class in this area

  • Antiparasitic

    17.2%
    Antimalarial17.2%
    Hydroxychloroquine Sulfate100%
    Part D≥16 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”